Thacker discusses FDA vaccine death coverup and conflicts

In a recent discussion, former Senate Investigator and award-winning journalist Paul Thacker spoke with Sharyl Attkisson about serious allegations regarding the FDA's handling of COVID-19 vaccine-related deaths. Thacker claims that the FDA has engaged in a cover-up concerning the number of deaths linked to these vaccines, raising concerns about transparency and accountability in public health messaging. He argues that such actions undermine public trust in health authorities and could have significant implications for vaccine policy and safety.

Thacker also addressed the media's reporting on Robert F. Kennedy Jr.'s new vaccine injury center at the National Institutes of Health (NIH). He criticized the media for what he perceives as unethical reporting practices that fail to accurately represent the center's mission and the importance of addressing vaccine injuries. This criticism highlights a broader concern about how the media portrays vaccine-related issues, often favoring narratives that align with mainstream public health positions while neglecting dissenting voices and alternative perspectives.

The conversation underscores the importance of independent journalism in scrutinizing the actions and narratives presented by health authorities and the media. Attkisson, who has been a vocal advocate for transparency and accountability in journalism, encourages her audience to seek out original reporting and to engage critically with the information they consume. She emphasizes the need for individuals to conduct their own research and form their own opinions rather than relying solely on mainstream sources.

In promoting her new book, "Follow the $cience: How Big Pharma Misleads, Obscures, and Prevails," Attkisson aims to shed light on the influence of pharmaceutical companies in shaping public health narratives. The book seeks to empower readers by providing insights into the complexities of public health communication and the potential conflicts of interest that may affect it. By encouraging critical thinking, Attkisson hopes to foster a more informed public discourse surrounding vaccine safety and efficacy.

Overall, the discussion between Thacker and Attkisson raises significant questions about the integrity of health communication, the role of the media in reporting on vaccine issues, and the need for transparency in public health policies. It serves as a call to action for individuals to be vigilant consumers of information and to advocate for accountability in both health authorities and the media landscape.